Literature DB >> 21824867

Plasticity of Ly-6C(hi) myeloid cells in T cell regulation.

Bing Zhu1, Jennifer K Kennedy, Yue Wang, Carolina Sandoval-Garcia, Li Cao, Sheng Xiao, Chuan Wu, Wassim Elyaman, Samia J Khoury.   

Abstract

CD11b(+)Ly-6C(hi) cells, including inflammatory monocytes (IMCs) and inflammatory dendritic cells (IDCs), are important in infectious, autoimmune, and tumor models. However, their role in T cell regulation is controversial. In this article, we show that T cell regulation by IMCs and IDCs is determined by their activation state and is plastic during an immune response. Nonactivated IMCs and IDCs function as APCs, but activated IMCs and IDCs suppress T cells through NO production. Suppressive IMCs are induced by IFN-γ, GM-CSF, TNF-α, and CD154 derived from activated T cells during their interaction. In experimental autoimmune encephalomyelitis, CD11b(+)Ly-6C(hi) cells in the CNS are increasingly activated from disease onset to peak and switch their function from Ag presentation to T cell suppression. Furthermore, transfer of activated IMCs or IDCs enhances T cell apoptosis in the CNS and suppresses experimental autoimmune encephalomyelitis. These data highlight the interplay between innate and adaptive immunity: immunization leads to the expansion of Ly-6C(hi) myeloid cells initially promoting T cell function. As T cells become highly activated in the target tissue, they induce activation and NO production in Ly-6C(hi) myeloid cells, which in turn suppress T cells and lead to the contraction of local immune response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824867      PMCID: PMC3159773          DOI: 10.4049/jimmunol.1100403

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  CD69 is an immunoregulatory molecule induced following activation.

Authors:  David Sancho; Manuel Gómez; Francisco Sánchez-Madrid
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

2.  A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis.

Authors:  Dana G Mordue; L David Sibley
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

3.  STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells.

Authors:  V Bronte; M Wang; W W Overwijk; D R Surman; F Pericle; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

5.  Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis.

Authors:  U C Sahrbacher; F Lechner; H P Eugster; K Frei; H Lassmann; A Fontana
Journal:  Eur J Immunol       Date:  1998-04       Impact factor: 5.532

6.  Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions.

Authors:  An D Billiau; Sabine Fevery; Omer Rutgeerts; Willy Landuyt; Mark Waer
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

7.  Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene.

Authors:  J E Fenyk-Melody; A E Garrison; S R Brunnert; J R Weidner; F Shen; B A Shelton; J S Mudgett
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

8.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

9.  Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells.

Authors:  Beatriz León; Gloria Martínez del Hoyo; Verónica Parrillas; Héctor Hernández Vargas; Paloma Sánchez-Mateos; Natividad Longo; María López-Bravo; Carlos Ardavín
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

10.  Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells.

Authors:  Oscar Goñi; Pilar Alcaide; Manuel Fresno
Journal:  Int Immunol       Date:  2002-10       Impact factor: 4.823

View more
  31 in total

1.  Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β.

Authors:  Jessica L Rastad; William R Green
Journal:  Virology       Date:  2016-09-12       Impact factor: 3.616

2.  Inhibiting the mobilization of Ly6C(high) monocytes after acute myocardial infarction enhances the efficiency of mesenchymal stromal cell transplantation and curbs myocardial remodeling.

Authors:  Wenbin Lu; Yong Tang; Ziwei Zhang; Xiaofeng Zhang; Yuyu Yao; Cong Fu; Xin Wang; Genshan Ma
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease.

Authors:  Kristen R Crook; Mengyao Jin; Michael F Weeks; Rishi R Rampersad; Robert M Baldi; Amy S Glekas; Yajuan Shen; Denise A Esserman; Paul Little; Todd A Schwartz; Peng Liu
Journal:  J Leukoc Biol       Date:  2015-01-12       Impact factor: 4.962

Review 4.  Monocyte differentiation and antigen-presenting functions.

Authors:  Claudia V Jakubzick; Gwendalyn J Randolph; Peter M Henson
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

5.  Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.

Authors:  Vrajesh V Parekh; Lan Wu; Danyvid Olivares-Villagómez; Keith T Wilson; Luc Van Kaer
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

6.  Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Subbulaxmi Trikudanathan; Alla L Zozulya; Carolina Sandoval-Garcia; Jennifer K Kennedy; Olga Atochina; Thomas Norberg; Bastien Castagner; Peter Seeberger; Zsuzsa Fabry; Donald Harn; Samia J Khoury; Indira Guleria
Journal:  Clin Immunol       Date:  2011-12-30       Impact factor: 3.969

7.  Role of myeloid-derived suppressor cells in autoimmune disease.

Authors:  Kristen R Crook; Peng Liu
Journal:  World J Immunol       Date:  2014-03-27

8.  Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Claudia Cantoni; Francesca Cignarella; Laura Ghezzi; Bob Mikesell; Bryan Bollman; Melissa M Berrien-Elliott; Aaron R Ireland; Todd A Fehniger; Gregory F Wu; Laura Piccio
Journal:  Acta Neuropathol       Date:  2016-10-04       Impact factor: 17.088

9.  Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.

Authors:  Darren J Lee; Andrew W Taylor
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 10.  Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.

Authors:  Etty N Benveniste; Yudong Liu; Braden C McFarland; Hongwei Qin
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.